Skip to main content
. 2018 Apr 1;20(4):257–262. doi: 10.1089/dia.2017.0346

Table 3.

Glycemic Outcomes Over the 36-H Hybrid Closed-Loop Phase

Parameter Adultsa(n = 24) Adults (n = 10) Adolescents (n = 12) Pediatrics (n = 12)
Mean sensor glucose, mg/dL 161.5 (20.1) 155.0 (14.8) 153.4 (21.6) 156.9 (20.4)
Standard deviation, mg/dL 54.0 46.2 48.6 53.3
Coefficient of variation, % 33.4 29.8 31.8 34.0
Percentage time in glucose range
 <54 mg/dL 0.1 (0.3) 0.1 (0.3) 0.2 (0.3) 0.2 (0.7)
 <60 mg/dL 0.2 (0.6) 0.2 (0.6) 0.7 (0.9) 0.6 (1.2)
 <70 mg/dL 0.7 (1.7) 0.7 (1.2) 2.0 (2.4) 2.0 (2.6)
 70 to 140 mg/dL 41.5 (18.1) 41.9 (16.3) 40.2 (15.5) 39.4 (16.1)
 70 to 180 mg/dL 69.5 (14.4) 73.0 (15.0) 72.6 (15.5) 70.1 (12.3)
 >180 mg/dL 29.7 (14.4) 26.3 (14.4) 25.4 (16.1) 27.9 (13.2)
 ≥250 mg/dL 8.0 (7.5) 3.6 (3.7) 4.9 (6.3) 6.7 (5.6)
 ≥300 mg/dL 2.0 (2.9) 0.5 (1.1) 0.1 (0.5) 1.0 (2.2)

Results are sensor glucose values, mean (standard deviation) unless otherwise indicated; SI conversion factor to convert glucose to mmol/L, multiply by 0.0555.

a

Initial 24 adult subjects enrolled received 80% meal bolus; all subjects enrolled subsequently received 100% meal bolus.